Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)

Completed

Conditions studied: Schizophrenia

In brief

The purpose of this study is to examine treatment practices of adult schizophrenia patients by their own doctors, and to assess patient outcomes when treated with long-acting risperidone injection over a two-year period of observation.

Key facts

Study ID

NCT00246194

Run by

Janssen, LP

People needed

532

Starts

2004-09-01

Expected to finish

2007-11-01

Last updated by the study team

2014-04-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients had schizophrenia (disorganized, catatonic, paranoid, residual, or undifferentiated) that met disease diagnostic criteria as defined in Diagnostic and Statistical Manual of Mental Disorders IV ([DSM-IV]
• Requiring new treatment with long-acting risperidone injectable
• Patients were cooperative, reliable, and able to complete all aspects of the protocol

You may not qualify if…

• Use of an investigational drug in the past 30 days
• At risk to self or others

Where it is running

• Study site — Rockville, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.